{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T01:59:54Z","timestamp":1695520794281},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0066343","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T21:05:12Z","timestamp":1371589512000},"page":"e66343","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L\/TRAIL"],"prefix":"10.1371","volume":"8","author":[{"given":"Vanessa","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Bouralexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/CCO.0b013e328331c794","article-title":"Bisphosphonates in breast cancer: Teaching an old dog new tricks","volume":"21","author":"MC Winter","year":"2009","journal-title":"Current Opinion in Oncology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1677\/erc.0.0070271","article-title":"Mechanisms in the skeletal complications of breast cancer","volume":"7","author":"TJ Martin","year":"2000","journal-title":"Endocr Relat Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"LJ Suva","year":"1987","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"TA Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-05-2814","article-title":"Parathyroid hormone-related protein localization in breast cancers predict improved prognosis","volume":"66","author":"MA Henderson","year":"2006","journal-title":"Cancer Res"},{"key":"ref6","first-page":"5076","article-title":"Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases","volume":"53","author":"Z Bouizar","year":"1993","journal-title":"Cancer Research"},{"key":"ref7","first-page":"3059","article-title":"Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites","volume":"51","author":"GJ Powell","year":"1991","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0959-8049(05)80127-3","article-title":"Parathyroid hormone related protein and skeletal morbidity in breast cancer","volume":"28","author":"NJ Bundred","year":"1992","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jnci\/93.3.234","article-title":"Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases","volume":"93","author":"M Henderson","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"SR Wiley","year":"1995","journal-title":"Immunity"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0960-9822(09)00456-4","article-title":"Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA","volume":"6","author":"SA Marsters","year":"1996","journal-title":"Current Biology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family","volume":"271","author":"RM Pitti","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"G Pan","year":"1997","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"G Pan","year":"1997","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjc.6605507","article-title":"Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer","volume":"102","author":"T Trarbach","year":"2010","journal-title":"Br J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lungcan.2007.12.011","article-title":"Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer","volume":"61","author":"FA Greco","year":"2008","journal-title":"Lung Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"RJ Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1210\/endo.141.5.7470","article-title":"Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide","volume":"141","author":"M Falzon","year":"2000","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/endo.143.2.8645","article-title":"Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells","volume":"143","author":"VA Tovar Sepulveda","year":"2002","journal-title":"Endocrinology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1359\/jbmr.2001.16.12.2173","article-title":"Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells","volume":"16","author":"C Luparello","year":"2001","journal-title":"J Bone Miner Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1210\/mend.16.2.0775","article-title":"Nuclear transport of parathyroid hormone (PTH)-related protein is dependent on microtubules","volume":"16","author":"MH Lam","year":"2002","journal-title":"Mol Endocrinol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/physrev.1996.76.1.127","article-title":"Defining the roles of parathyroid hormone-related protein in normal physiology","volume":"76","author":"WM Philbrick","year":"1996","journal-title":"Physiol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10408369509084687","article-title":"Parathyroid hormone-related protein","volume":"32","author":"JM Moseley","year":"1995","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.physiol.60.1.431","article-title":"The physiology of parathyroid hormone-related protein: an emerging role as a developmental factor","volume":"60","author":"JJ Wysolmerski","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1242\/dev.125.7.1285","article-title":"Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development","volume":"125","author":"JJ Wysolmerski","year":"1998","journal-title":"Development"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1242\/dev.126.16.3485","article-title":"Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development","volume":"126","author":"ME Dunbar","year":"1999","journal-title":"Development"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1242\/dev.128.4.513","article-title":"Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development","volume":"128","author":"J Foley","year":"2001","journal-title":"Development"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1242\/dev.121.11.3539","article-title":"Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development","volume":"121","author":"JJ Wysolmerski","year":"1995","journal-title":"Development"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0167-0115(01)00248-8","article-title":"Overexpression of parathyroid hormone-related protein promotes cell growth in the rat intestinal cell line IEC-6","volume":"99","author":"Y Ye","year":"2001","journal-title":"Regulatory Peptides"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jcp.21055","article-title":"Parathyroid hormone-related protein (PTHrP) inhibits mitochondrial-dependent apoptosis through CK2","volume":"212","author":"LE Okoumassoun","year":"2007","journal-title":"Journal of Cellular Physiology"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Luparello C, Sirchia R, Lo Sasso B (2007) Midregion PTHrP regulates Rip1 and caspase expression in MDA-MB231 breast cancer cells. Breast Cancer Res Treat.","DOI":"10.1007\/s10549-007-9816-0"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1074\/jbc.274.11.7391","article-title":"Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha","volume":"274","author":"MH Lam","year":"1999","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1034\/j.1600-0854.2001.21110.x","article-title":"Dynamics of leptomycin B-sensitive nucleocytoplasmic flux of parathyroid hormone-related protein","volume":"2","author":"MH Lam","year":"2001","journal-title":"Traffic"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"18559","DOI":"10.1074\/jbc.274.26.18559","article-title":"Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization","volume":"274","author":"MH Lam","year":"1999","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1006\/bbrc.2001.4607","article-title":"Molecular dissection of the importin beta1-recognized nuclear targeting signal of parathyroid hormone-related protein","volume":"282","author":"MH Lam","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"H Walczak","year":"1999","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-05-4386","article-title":"Apo2l\/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model","volume":"66","author":"lM Thai","year":"2006","journal-title":"Cancer Research"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1158\/1078-0432.CCR-08-2444","article-title":"Apo2L\/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma","volume":"15","author":"A Labrinidis","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref39","first-page":"5390","article-title":"Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand\/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo","volume":"63","author":"TR Singh","year":"2003","journal-title":"Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-008-9924-5","article-title":"TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype","volume":"113","author":"M Rahman","year":"2009","journal-title":"Breast Cancer Research and Treatment"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ijc.21939","article-title":"The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L\/TRAIL","volume":"119","author":"LM Butler","year":"2006","journal-title":"Int J Cancer"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/j.1349-7006.2007.00632.x","article-title":"Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression","volume":"98","author":"XX Wu","year":"2007","journal-title":"Cancer Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10495-006-0025-9","article-title":"Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis","volume":"12","author":"E Saulle","year":"2007","journal-title":"Apoptosis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/sj.onc.1209516","article-title":"Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: Enhanced effects in vitro and dose-dependent growth delay in vivo","volume":"25","author":"P Marini","year":"2006","journal-title":"Oncogene"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-07-0812","article-title":"Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels","volume":"67","author":"ST Nawrocki","year":"2007","journal-title":"Cancer Research"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1074\/jbc.M410660200","article-title":"Receptor-selective mutants of apoptosis-inducing ligand 2\/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of Death Receptor (DR) 5 than DR4 to apoptosis signaling","volume":"280","author":"RF Kelley","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1158\/0008-5472.CAN-05-2801","article-title":"TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies","volume":"65","author":"M MacFarlane","year":"2005","journal-title":"Cancer Research"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, <etal>et al<\/etal>.. (2007) Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin. Molecular Cancer 6.","DOI":"10.1186\/1476-4598-6-66"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/MCB.15.8.4064","article-title":"Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death","volume":"15","author":"JE Henderson","year":"1995","journal-title":"Mol Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0066343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T17:42:51Z","timestamp":1645810971000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0066343"}},"subtitle":[],"editor":[{"given":"Rakesh K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0066343","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}